To collect and summarize parameters used by gadoxetic acid-enhanced MR imaging (GD-EOB-DTPA-enhanced MRI) for staging of liver fibrosis (LF) and evaluate diagnostic performance. A systematic literature search was performed in PubMed, Web of science, Embase and Medline database. Studies used frequently-used parameter were included. Pooled weighted mean difference (WMD) was applied to determine the clinical significance. Pooled sensitivity, specificity, and summary receiver operating characteristics (SROC) curve were calculated to evaluate diagnostic performance. Finally, 5 studies were included, and contrast enhancement index (CEI) was the most frequently-used parameter, which was considered to be an efficient biomarker in the staging of LF.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords